S. Bredl

Most-cited papers

1. Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells

   A. Audigé, Mary-Aude Rochat, Duo Li, S. Ivic +9 more

   2017BMC Immunology53 citations Open access

   Semantic Scholar

   Save

2. False-negative serology in patients with acute parvovirus B19 infection.

   S. Bredl, A. Plentz, J. Wenzel, H. Pfister +2 more

   2011Journal of Clinical Virology53 citations

   Semantic Scholar

   Save

3. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.

   S. Kuate, C. Stahl-Hennig, H. Stoiber, G. Nchinda +12 more

   2006Virology47 citations Open access

   Semantic Scholar

   Save

4. EBV renders B cells susceptible to HIV-1 in humanized mice

   Donal McHugh, R. Myburgh, N. Caduff, M. Spohn +30 more

   2020Life Science Alliance34 citations Open access

   Semantic Scholar

   Save

5. Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA Vaccine

   Katharina Böckl, J. Wild, S. Bredl, Kathrin Kindsmüller +2 more

   2012PLoS ONE28 citations Open access

   Semantic Scholar

   Save

6. Seroepidemiology of human bocavirus in Apulia, Italy.

   M. Guido, A. Zizza, S. Bredl, J. Lindner +4 more

   2012Clinical Microbiology and Infection28 citations Open access

   Semantic Scholar

   Save

7. Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes.

   C. Speth, S. Bredl, M. Hagleitner, J. Wild +5 more

   2008Virology18 citations Open access

   Semantic Scholar

   Save

8. Optimizing Synthetic miRNA Minigene Architecture for Efficient miRNA Hairpin Concatenation and Multi-target Gene Knockdown

   F. Rousset, P. Salmon, S. Bredl, Ophélie Cherpin +8 more

   2018Molecular Therapy: Nucleic Acids16 citations Open access

   Semantic Scholar

   Save

9. The Humanized Mouse Model: What Added Value Does It Offer for HIV Research?

   Luca Baroncini, S. Bredl, Kadzioch P. Nicole, R. Speck

   2023Pathogens15 citations Open access

   Semantic Scholar

   Save

10. cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice

    Maarja Gruenbach, Christina K. S. Muller, E. Schlaepfer, Luca Baroncini +7 more

    2022Journal of Virology5 citations Open access

    Semantic Scholar

    Save

11. Pro-inflammatory macrophages suppress HIV replication in humanized mice and ex vivo co-cultures

    Luca Baroncini, Christina K. S. Muller, N. Kadzioch, R. Wolfensberger +4 more

    2024Frontiers in Immunology3 citations Open access

    Semantic Scholar

    Save

12. Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas

    Takako Tabata, M. Petitt, Julia Li, X. Chi +8 more

    2022Vaccines2 citations Open access

    Semantic Scholar

    Save

13. Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells

    A. Audigé, Mary-Aude Rochat, Duo Li, Sandra Ivic +9 more

    2017BMC Immunology2 citations Open access

    Semantic Scholar

    Save

14. RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug

    N. Jarzębska, Marina Tusup, J. Frei, T. Weiss +9 more

    2022Oncoimmunology1 citations Open access

    Semantic Scholar

    Save

15. Development of an off-the-shelf CAR T-cell therapy for HIV: a step towards a universally accessible advanced therapy

    T. Mlambo, A. Roussel-Gervais, S. Ilmjarv, A. Sakic +7 more

    20211 citations

    Semantic Scholar

    Save

16. P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses

    J. Wild, J. Köstler, S. Bredl, K. Böckl +2 more

    2009Retrovirology0 citations Open access

    Semantic Scholar

    Save